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Diabetes Mellitus (DM) is associated with pathological changes in the central nervous system (SNC) as well as alterations in
oxidative stress. Thus, the main objective of this study was to evaluate the eﬀects of the animal model of diabetes induced by
alloxan on memory and oxidative stress. Diabetes was induced in Wistar rats by using a single injection of alloxan (150mg/kg),
and ﬁfteen days after induction, the rats memory was evaluated through the use of the object recognition task. The oxidative
stress parameters and the activity of antioxidant enzymes, superoxide dismutase (SOD), and catalase (CAT) were measured in
the rat brain. The results showed that diabetic rats did not have alterations in their recognition memory. However, the results did
show that diabetic rats had increases in the levels of superoxide in the prefrontal cortex, and in thiobarbituric acid reactive species
(TBARS) production in the prefrontal cortex and in the amygdala in submitochondrial particles. Also, there was an increase in
protein oxidation in the hippocampus and striatum, and in TBARS oxidation in the striatum and amygdala. The SOD activity was
decreased in diabetic rats in the striatum and amygdala. However, the CAT activity was increased in the hippocampus taken from
diabetic rats. In conclusion, our ﬁndings illustrate that the animal model of diabetes induced by alloxan did not cause alterations
in the animals’ recognition memory, but it produced oxidants and an imbalance between SOD and CAT activities, which could
contribute to the pathophysiology of diabetes.
1.Introduction
Diabetes Mellitus (DM) is a heterogeneous metabolic disor-
der characterized by hyperglycemia [1]. In type 1 diabetes
(DM1), which generally develops at a young age (children
and early adulthood), the principal defect is an auto-
immune-mediated destruction of pancreatic cells, leading to
insulin deﬁciency [2]. In type 2 diabetes (DM2) the principal
defect is insulin resistance, leading to a relative insulin deﬁ-
ciency in the liver and peripheral tissues, which leads to overt
hyperglycaemia [3]. The hyperglycaemia in turn causes upto
a fourfold increase in neuronal glucose, with intracellular
glucose metabolism then leads to neuronal damage [4]. In
addition to this, the current therapeutic strategies for DM2
are limited [5].
In both the human and animal models, DM is associated
with pathological changes in the central nervous system
(SNC) that lead to cognitive and aﬀective deﬁcits, and to an
increased risk of brain vascular complications [3]. In the ani-
mal models of diabetes, several brain alterations have been
described, such as increased hippocampal astrocytic reactiv-
ity, impaired synaptic plasticity, vascular changes, decreased2 Experimental Diabetes Research
dendritic complexity, and disturbed neurotransmission [6].
Recently, a signiﬁcant body of evidence has accumulated
to indicate that diabetes has detrimental eﬀects on brain
function. A number of investigations have been performed
to indicate that memory loss is a consequence of both type I
and type II diabetes [7]. Some authors have also reported a
reduction in the length and a simpliﬁcation of the dendritic
trees of the hippocampal pyramidal cells in diabetic rodents
[6]. There is evidence from the animal models showing that
changes in dendritic morphology, probably associated with
synaptic disturbances, correlate with alterations in memory
and learning abilities [8]. Mitochondria are the principal
source of reactive oxygen species (ROS) in cells, as the result
of imperfectly coupled electron transport. Oxidative stress
is widely accepted as playing a key mediatory role in the
development and progression of diabetes and its complica-
tions, due to the increased production of free radicals and
impaired antioxidant defenses [9]. Several mechanisms can
contribute to increased oxidative stress in diabetic patients,
especially chronic exposure to hyperglycemia. Accumulated
evidence points out that hyperglycemia can lead to elevated
ROS and reactive nitrogen species (RNS) production by the
mitochondrial respiratory system [10], glucose autoxidation
[11], activation of the polyol pathway [12], formation of
advanced glycation end products (AGEs) [13], antioxidant
enzyme inactivation [14] and an imbalance of glutathione
redox status [15]. Hyperglycemia can promote an impor-
tant oxidative imbalance, favoring the production of free
radicals and the reduction of antioxidant defenses. At high
concentrations, ROS/RNS can lead to damage to the major
components of the cellular structure, including nucleic
acids, proteins, amino acids, and lipids [16]. Such oxidative
modiﬁcations in the diabetes condition would aﬀect several
cell functions, metabolism, and gene expression, which in
turn can cause other pathological conditions [17].
It is important to note that the animal models of diabetes
are very useful tools to gain new insights into human dia-
betes. Animal models induced by chemicals, such as alloxan,
exhibit a syndrome of insulin resistance and type 2 diabetes
[5]. Thus, the main objective of our study was to evaluate the
eﬀects of the animal model of diabetes induced by alloxan
on the object recognition task and on the parameters of oxi-
dativestressinthehippocampus, striatum,prefrontalcortex,
and amygdala.
2.MaterialandMethods
2.1. Animals. Male Adult Wistar rats (60 days old) were
obtained from the UNESC (Universidade do Extremo Sul
Catarinense, Crici´ uma, SC, Brazil) breeding colony. They
were housed ﬁve per cage with food and water available ad
libitumandweremaintainedona12hlight/darkcycle(lights
on at 7:00 a.m.). All experimental procedures involving
animals were performed in accordance with the NIH Guide
for the Care and Use of Laboratory Animals and the
Brazilian Society for Neuroscience and Behavior (SBNeC)
recommendations for animal care and with approval by the
local Ethics Committee under protocol number 16/2010.
2.2. Diabetes Induction. Diabetes was induced in rats by
using a single intraperitoneal injection of alloxan from
Sigma Chemical Co. (St Louis, MO, USA) dissolved in
a physiological saline (0.9% NaCl) solution (150mg/kg),
whereas the control group received only a saline injection
[18]. Both groups were injected after an 18h fasting period
(60–70mg/dL blood glucose). Fasting animals are more
susceptible to alloxan probably due to partial protection by
increased blood glucose [19]. All induced rats showed hyper-
glycemia (400–600mg/dL) 48h after alloxan administration.
During the course of the experiment, the blood glucose
level was monitored on a daily basis with commercial kits
by performing a small puncture in the animals’ tail. This
methodology is quick and noninvasive, subjecting the rats
to a negligible level of stress. At the end of the study, rats
with glycemia between 400 and 600mg/dL were considered
diabetic [20]. Fifteen days after the induction of diabetes,
based in previous studies [21], all rats were submitted to the
object recognition task, after which the animals were killed
by decapitation and a biochemical analysis was undertaken
of the brain tissues.
2.3. Object Recognition Task. The object recognition task
took place in a 40 × 60cm open ﬁeld surrounded by 50cm
high walls made of ply wood with a frontal glass wall. The
ﬂoor of the open ﬁeld was divided into 12 equal rectangles
by black lines. All animals (alloxan or saline; n = 10–
15 animals per group) were submitted to a habituation
session where they were allowed to freely explore the open
ﬁeld for 5min. No objects were placed in the box during
the habituation trial. Twenty-four hours after habituation,
training was conducted by placing the individual rats in
the open ﬁeld for 5min, in which two identical objects
(objects A1 and A2; both being cubes) were positioned in
two adjacent corners, 10cm from the walls. In a short-term
recognition memory test given 1.5h after training, the rats
explored the open ﬁeld for 5min in the presence of one
familiar (A) and one novel (B, a rectangle) object. In a
long-term recognition memory test given 24h after training,
the rats explored the open ﬁeld for 5min in the presence
of one familiar (A) and one novel (C, a pyramid with a
square-shaped base) object. All objects had similar textures
(smooth), colors (blue), and sizes (weight 150–200g) but
distinctive shapes. A recognition index calculated for each
animal was calculated during the test session. It reports the
ratio TB/(TA + TB) (TA = time spent exploring the familiar
objectA;TB =timespentexploringthenovelobjectB)andit
reports the ratio TC/(TA + TC) (TA = time spent exploring
the familiar object A; TC = time spent exploring the novel
object C). Between trials, the objects were washed with
10% ethanol solution. Exploration was deﬁned as sniﬃng
(exploring the object 3–5cm away from it) or touching the
object with the nose and/or forepaws [21].
2.4.OxidativeStressParameters. Immediatelyaftertheobject
recognition task, the animals were sacriﬁced by decapita-
tion and the following brain areas; the prefrontal cortex,
amygdala, hippocampus and striatum (n = 4–6 animals perExperimental Diabetes Research 3
group) were dissected according to the stereotaxic atlas [22]
in ice-cold buﬀer, in a Petri dish. Submitochondrial particles
were prepared in parallel from the four brain regions of each
animal. For biochemical analysis in total tissue, the brain
structures were rapidly frozen and stored at −70◦C.
2.4.1. Mitochondrial Isolation. Rat brain homogenates were
centrifuged at 700g for 10min to discard nuclei and
cell debris and the pellet was then washed to enrich the
supernatant that was centrifuged at 700g for 10min. The
obtained pellet, washed and resuspended in the same buﬀer,
was considered to consist mainly of intact mitochondria able
to carry out oxidative phosphorylation. The operations were
c a r r i e do u ta t0 – 2 ◦C. Submitochondrial particles (SMPs)
were obtained by freezing and thawing (three cycles) of
isolated mitochondria. For superoxide production measure-
ments, SMP were washed twice with 140mM KCl, 20mM
Tris-HCl (pH 7.4) and suspended in the same medium [23].
2.4.2. Superoxide Production in Submitochondrial Particles
of the Rat Brain. Superoxide production was determined
in washed brain SMP using a spectrophotometric assay
based on superoxide-dependent oxidation of epinephrine
to adrenochrome at 37◦C( C 480nm = 4.0mM−1cm−1). The
reaction medium consisted of 0.23M mannitol, 0.07M
sucrose, 20mM Tris-HCl (pH 7.4), SMP (0.3–1.0mg pro-
tein/mL), 0.1μM catalase, and 1mM epinephrine. NADH
(50μM) and succinate (7mM) were used as substrates and
rotenone (1μM) and antimycin (1μM) were added as spe-
ciﬁc inhibitors, respectively, to assay O2
− production at the
NADH dehydrogenase and at the ubiquinone-cytochrome b
region. Superoxide dismutase (SOD) was used at 0.1–0.3μM
ﬁnal concentration to give assay speciﬁcity [24].
2.4.3. Thiobarbituric Acid Reactive Species Formation. To
determine oxidative damage in lipid, we measured the
formation of thiobarbituric acid reactive species (TBARS)
during an acid-heating reaction, as previously described
[25]. The samples were mixed with 1mL of trichloroacetic
acid 10% and 1mL of thiobarbituric acid 0.67%, and then
heated in a boiling water bath for 30min. Malondialdehyde
equivalents were determined in tissue and in submitochon-
drial particles of the rat brain spectrophotometrically by the
absorbance at 532nm.
2.4.4. Carbonyl Protein Formation. Oxidative damage to
proteins was assessed by the determination of carbonyl
groups content based on the reaction with dinitrophenylhy-
drazine (DNPH), as previously described [26]. Proteins were
precipitated by the addition of 20% trichloroacetic acid and
were redissolved in DNPH. The absorbance was monitored
spectrophotometrically at 370nm.
2.4.5. Superoxide Dismutase Activity. This method for the
assay of superoxide dismutase (SOD) activity is based on
the capacity of pyrogallol to autoxidize, a process highly
dependent on O2
−2;as u b s t r a t ef o rS O D[ 27]. The inhibi-
tion of autoxidation of this compound thus occurs when
SOD is present, and the enzymatic activity can be then
indirectly assayed spectrophotometrically at 420nm, using a
double-beam spectrophotometer with temperature control.
A calibration curve was performed using puriﬁed SOD as
the standard, in order to calculate the speciﬁc activity of
SOD present in the samples. A 50% inhibition of pyrogallol
autoxidation is deﬁned as 1 unit of SOD, and the speciﬁc
activity is represented as units per mg of protein.
2.4.6. Catalase Activity. The catalase (CAT) activity was
assayed using a double-beam spectrophotometer with tem-
perature control. This method is based on the disappearance
of H2O2 at 240nm in a reaction medium containing 20mM
H2O2, 0.1% Triton X-100, 10mM potassium phosphate
buﬀer, pH 7.0, and 0.1–0.3mg protein/mL [28]. One CAT
unit is deﬁned as 1mol of hydrogen peroxide consumed per
minute, and the speciﬁc activity is reported as units per mg
protein.
2.4.7. Protein Determination. All biochemical measures were
normalized to the protein content with bovine albumin as
standard [29].
2.5. Statistical Analysis. In the open ﬁeld test, the diﬀerences
between training test sessions were analyzed by the paired
Student’s t-test. Data for recognition indexes are reported
as median ± interquartile ranges (25 and 75). Comparisons
among groups were performed using the Kruskal-Wallis
test followed by Mann-Whitney test when necessary. The
oxidative stress parameters were analyzed by Student’s t-test
forunpaireddataandarereportedasmean ±S.E.M.P values
less than 0.05 were considered to be statistically signiﬁcant.
3. Results
As depicted in Figure 1, in the object recognition task, no
statistical diﬀerences were observed in the saline or alloxan
groups in the training session (P>0.05). In the control rats
group, 1.5h after the training session (short-term recogni-
tion memory), we observed an increase in the recognition
index compared to the training session, and 24h after
the training session (long-term recognition memory) there
was an increase in the recognition index, compared to the
training session or to the short-term memory tests (P<0.05;
Figure 1). In the diabetic rats induced by alloxan, there was
an increase in the recognition index after 24h, but not 1.5h
after the training session (P<0.05; Figure 1).
In diabetic rats, there was an increase in the superoxide
submitochondrial particles in the prefrontal cortex (P<
0.05; Figure 2(a)) and an increase in the TBARS submito-
chondrial particles in the prefrontal cortex and amygdala
(Figure 2(b)). In diabetic rats it was shown that there was
an increase in the carbonyl proteins in the hippocampus
and striatum (P<0.05; Figure 3(a)) and an increase in the
TBARS oxidation in the striatum and amygdala (P<0.05;
Figure 3(b)). The SOD activity was decreased in diabetic
rats in the striatum and amygdala (P<0.05; Figure 4(a)).4 Experimental Diabetes Research
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Figure 1: The eﬀects of the animal model of diabetes induced by
alloxan on the object recognition task. Results are reported as
median ±interquartileranges of therecognition indexes intraining
and short- and long-term memory retention test trials. N = 10–15
per group, ∗P<0.05 diﬀerence from the training session and #P<
0.05 diﬀerence from the training from 1.5h retention, according to
Kruskal-Wallis test.
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Figure 2: The eﬀects of the animal model of diabetes induced by
alloxan on the superoxide (a) and TBARS (b) production in sub-
mitochondrial particles in the hippocampus, striatum, prefrontal
cortex and amygdala. Results are reported as mean +S.E.M.N = 4–
6p e rg r o u p ,∗P<0.05 diﬀerence from the saline group, according
to the Student t-test.
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Figure 3: The eﬀects of the animal model of diabetes induced by
alloxanonTBARSproduction(a)andcarbonylformation(b)inthe
hippocampus, striatum, prefrontal cortex, and amygdala. Results
are reported as mean + S.E.M. N = 4–6 per group, ∗P<0.05
diﬀerence from the saline group, according to the Student’s t-test.
However,theCATactivitywasincreasedinthehippocampus
from diabetic rats (P<0.05; Figure 4(b)).
4. Discussion
Experimental diabetes models can be induced by chemicals
that selectively destroy the insulin-producing β-cells in the
pancreas [30]. One of the most commonly used chemicals
is alloxan. This drug induces diabetes by intracellular
generation of ROS formed in a cyclic reaction involving
alloxananditsreducedproductcalleddialuricacid[18],with
subsequent inhibition of insulin synthesis and secretion.
Recently, a signiﬁcant body of evidence has accumulated
to indicate that diabetes has detrimental eﬀects on brain
function. In fact, hypoglycemia and diabetes insults are
related with damage in the hippocampus and hypothalamus,
which are the brain areas associated with memory and plas-
ticity functions [31]. A number of investigations have been
performed to indicate that memory loss is a consequence
of both type I and type II diabetes [3, 32]. However, the
exact mechanism(s) as to how diabetic conditions could
aﬀect memory activity remains to be fully characterized. In
the present study our results showed that in diabetic rats,
there was an increase in the recognition index 24h afterExperimental Diabetes Research 5
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Figure 4: The eﬀects of the animal model of diabetes induced by
alloxan on the superoxide dismutase (a) and catalase (b) activities
in the hippocampus, striatum, prefrontal cortex, and amygdala.
Results are reported as mean + S.E.M. N = 4–6 per group, ∗P<
0.05 diﬀerence from the saline group, according to the Student’s t-
test.
the training session, indicating that diabetic rats did not
alter recognition memory, when subjected to the object
recognition task. Contrary to this, another study showed
a signiﬁcant reduction of memory formation, evaluated in
the passive avoidance test in streptozotocin-induced diabetic
mice [7]. The authors suggest that the overexpressed β-
amyloid precursor might be one of the underlying factors
causing memory deﬁcit.
Diﬀerences between these studies could be related with
the animal model of diabetes and tests used to evaluate
memory. Although some studies have shown that oxidative
stress induces signiﬁcant deﬁcits in cognitive performance
(learning ability and memory retention) [33], in the present
ﬁndings we did not show this correlation. It is impor-
tant to note that during the formation of memories the
activation of speciﬁc receptors and of several molecular
cascades is required to convert extracellular signals that
lead to changes in neuronal connectivity [34], which were
probablynotalteredinthebrainsofalloxan-induceddiabetic
rats. For example, we recently demonstrated that brain-
derived neurotrophic factor (BDNF) levels did not alter in
the hippocampus from alloxan-induced diabetic rats [35].
BDNF is a neurotrophin which has an important role in
hippocampal-dependent forms of memory [36]. Thus, the
ﬁndings of the present study on recognition memory could
be related, at least in part, because the animal model of
diabetes induced by alloxan did not alter BDNF levels.
A previous study showed that alloxan-induced diabetes
is associated with changes in the uptake of insulin by the
brain, which includes increased binding to the capillary bed
comprising the blood brain barrier and increased transport
across the blood brain barrier [37]. Moreover, studies related
that oxidative stress impacts several brain areas, such as the
forebrain, cerebellum, and brain stem [31, 38]. Thus, in the
present study we evaluated oxidative stress parameters in
diﬀerent brain areas, namely, the hippocampus, striatum,
prefrontal cortex, and amygdala. Uncontrolled ROS produc-
tion could lead to damage in cellular macromolecules (DNA,
lipids, and protein) and other small antioxidant molecules
[39], contributing to the progress of diabetic complications.
Still, research indicates that obesity and hyperglycemia are
associated with increases in the ROS production [40, 41]. In
the present study we observed an increase in the superoxides
in the prefrontal cortex and an increase in TBARS in
the prefrontal cortex and amygdala in submitochondrial
particles. Diabetes causes mitochondrial superoxide over-
production and this increased superoxide production is the
major mediator of diabetes tissue damage [41]. In fact, in
diabetic cells with a high intracellular glucose concentration,
there is more glucose-derived pyruvate being oxidized in
the tricarboxylic acid cycle, increasing the ﬂux of electron
donors (NADH and FADH2) into the electron transport
chain [42]. Thus, electron transfer inside complex III is
blocked [43], causing the electrons to use coenzyme Q
as a backup, which donates the electrons one at a time
to molecular oxygen, thereby generating superoxide [42].
The mitochondria are an organelle and have the ability to
generate superoxides at complexes I and III [44, 45]. In
addition to this, in brain tissue, complexes I and III have
been attributed to major ROS production [44, 45]. In fact, a
study from our group demonstrated that in alloxan-induced
diabetic rats there were alterations in the mitochondrial
respiratory chain [20]. Thus we suggest that alloxan-induced
diabetic-like symptoms may provide a useful animal model
to test the hypothesis of the involvement of oxidative stress
in diabetes. Our results also showed an increase in carbonyl
protein in the hippocampus, and amygdala and an increase
in TBARS oxidation in the striatum and amygdala from
diabetic animals. We discovered from our data that the
TBARS levels in mitochondrial particles and in tissues were
diﬀerent, but our analysis was conducted in diﬀerent areas,
involving separate samples from submitochondrial particles
andanotherfromtissue.Itisknownthatthemitochondria is
a major producer of ROS [42], which in turn causes damage
in lipids, which may explain the increase in TBARS in
submitochondrial particles inthe prefrontalcortex.Recently,
Chang et al. [46] showed an increase in the carbonyl
protein in the renal tissues from diabetic animals induced
by streptozotocin. Additionally, similar to our ﬁndings, the
TBARS index was increased in the liver of rats that had
received a single injection of alloxan (150mg/kg) [30]. Also,6 Experimental Diabetes Research
there was shown to be an increase in the TBARS in the
plasma and hippocampus from diabetic animals induced by
streptozotocin [47]. Recently, [48] investigated the eﬀects
of agmatine, an antihyperglycemic and antioxidant, on
MDA and glutathione levels in the cerebral cortex and
hippocampus from diabetic rats. The authors found that
treatment with agmatine reduced oxidative stress markers
in the brain of diabetic rats. In addition, [48] showed that
brain regions diﬀer in their response to oxidative stress in
obese db/db mice. Still, silibinin, a compound with antioxi-
dant properties, provided eﬃcient neuroprotection in these
diabetic rats [48]. Thus, this suggests that diabetes is related
to oxidative stress in the brain.
The present ﬁndings showed that SOD activity decreased
in the striatum and amygdala. On the other hand, the CAT
activity increased in the hippocampus in diabetic animals.
SOD is a protective enzyme that can selectively scavenge
the superoxide anion radical (O2
−.) by catalyzing its dis-
mutation to hydrogen peroxide (H2O2)[ 49]. CAT catalyzes
degradation ofH2O2 to water and O2.Anotherstudyshowed
that SOD and CAT activities were increased in the livers
from alloxan-induced diabetic rats [31]. Also, Amer et al.
[50] demonstrated that polymorphisms of glutathione S-
transferase (an antioxidant enzyme) genes GSTM1 and
GSTT1 were associated with an increased risk of type 2 DM.
Interestingly, Di Naso et al. [51] reported that exogenous
antioxidant copper zinc superoxide dismutase (Cu/Zn SOD)
decreased liver peroxidation and increased nitric oxide
synthase (NOS) in diabetic rats. Moreover, Gibson et al.
[52]showedthatN-acetylcysteine(NAC),abiosyntheticpre-
cursor of the antioxidant glutathione, reduced thrombotic
propensity in type 2 diabetes patients, suggesting that this
eﬀect occurred by increasing the platelet antioxidant status
as a result of elevated glutathione synthesis.
An imbalance in the SOD/CAT ratio indicates the
generation of reactive species [53] ,w h i c hw e r er e p o r t e di n
the present study. In this context, the eﬀects of alloxan on
SOD/CAT turnover (by increasing CAT and decreasing SOD
activity) may result in antioxidant eﬀects. An imbalance
in the SOD/CAT ratio indicates the generation of reactive
species, which were reported in the present study. Thus,
considering the pathophysiology of diabetes, and the results
presented in the present work, it is sensible to suggest that
diﬀerences in oxidative stress parameters may be related, at
least in part, with brain metabolism. Another study from
our group also showed a decrease in SOD and an increase in
CAT activities in the brain of rats submitted to the chronic
mild stress procedure [54]. In fact, studies have reported
a relationship between diabetes and stress [55, 56] inclu-
sively,alloxan-induceddiabeticratspresenteddepressive-like
behaviour [20].
The cause of the overall oxidative imbalance demon-
strated in our study may be due to mitochondrial dysfunc-
tion. Recently, it was shown that alloxan-induced diabetic
rats presented alterations in the mitochondrial respiratory
chain, creatine kinase, and citrate synthase activities [20].
However, mitochondrial alteration could occur by oxidative
imbalance. In fact, ROS causes damage in the mitochondrial
oxidative phosphorilation [56]. In addition, Bhattacharya
et al. [57] reported decreased mitochondrial membrane
potential, enhanced cytochrome c release, reciprocal regula-
tion of the Bcl-2 family, and increases of caspases 3 and 9
in alloxan-induced diabetes. The authors also showed that
treatment with D-saccharic acid 1,4-lactone, a derivative of
D-glucaric acid which has antioxidant properties, counter-
acted these changes [57].
5. Conclusions
To our knowledge our data describes for the ﬁrst time,
the eﬀects of the animal model of diabetes induced by
alloxan on memory and oxidative stress parameters in the
rat brain. In conclusion, alloxan-induced diabetes did not
alterrecognitionmemory,butinducedoxidativedamageand
an imbalance between antioxidant enzymes, contributing, at
least in part, to the pathophysiology of diabetes.
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